Challenges in translating end points from trials to observational cohort studies in oncology
Anne Gulbech Ording,1 Deirdre Cronin-Fenton,1 Vera Ehrenstein,1 Timothy L Lash,1,2 John Acquavella,1 Mikael Rørth,1 Henrik Toft Sørensen1 1Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; 2Department of Epidemiology, Rollins&am...
Main Authors: | Ording AG, Cronin-Fenton D, Ehrenstein V, Lash TL, Acquavella J, Rørth M, Sørensen HT |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-06-01
|
Series: | Clinical Epidemiology |
Subjects: | |
Online Access: | https://www.dovepress.com/challenges-in-translating-end-points-from-trials-to-observational-coho-peer-reviewed-article-CLEP |
Similar Items
-
Lights and Shadows in Immuno-Oncology Drug Development
by: Milana Bergamino Sirvén, et al.
Published: (2021-02-01) -
Robotic-assisted prostatectomy and open radical retropubic prostatectomy for locally-advanced prostate cancer: multi-institution comparison of oncologic outcomes
by: Anup A. Vora, et al.
Published: (2013-03-01) -
Making Sense of Composite Endpoints in Clinical Research
by: Daniela Baracaldo-Santamaría, et al.
Published: (2023-06-01) -
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trialsResearch in context
by: Oriana Ciani, et al.
Published: (2023-11-01) -
Perspectives to mitigate payer uncertainty in health technology assessment of novel oncology drugs
by: Oriol Solà-Morales, et al.
Published: (2019-01-01)